Compare KEQU & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KEQU | CSBR |
|---|---|---|
| Founded | 1906 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.9M | 82.7M |
| IPO Year | 1995 | 2015 |
| Metric | KEQU | CSBR |
|---|---|---|
| Price | $37.12 | $5.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.2K | ★ 5.2K |
| Earning Date | 03-11-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | ★ 2.09 | N/A |
| Revenue | ★ $138,558,000.00 | $2,900,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | $17.70 | ★ N/A |
| Revenue Growth | ★ 7.72 | N/A |
| 52 Week Low | $30.33 | $5.50 |
| 52 Week High | $60.89 | $9.63 |
| Indicator | KEQU | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 48.75 |
| Support Level | $37.04 | $5.50 |
| Resistance Level | $41.26 | $6.28 |
| Average True Range (ATR) | 0.87 | 0.27 |
| MACD | 0.41 | 0.01 |
| Stochastic Oscillator | 74.62 | 34.40 |
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.